GW Pharmaceuticals has achieved one of its goals for this year - seeing Epidiolex approved for the treatment of seizures associated with tuberous sclerosis complex (TSC). The U.S. Food and Drug Administration announced approval of Epidiolex for TSC last Friday, a cannabidiol based medicine previously approved for treatment of seizures...
Western Australia's McGowan Government has awarded $300,000 to medical cannabis company Little Green Pharma (ASX:LGP). Little Green Pharma was the first Australian medicinal cannabis company to produce locally-grown medicines for patient use both here and for export markets. It's a vertically integrated business with operations ranging from cultivation and production...
The European Commission is poised to kill the EU's hemp sector claims the European Industrial Hemp Association (EIHA). It says the EC recently arrived at a preliminary conclusion that extracts from industrial hemp, which would include cannabidiol, qualify as drugs in EU legislation. This has thrown a spanner into the...
Research out of University of Newcastle in Australia indicates cannabis has the potential to kill or inhibit cancer cells without impacting normal cells. Cancer researcher Dr Matt Dun collaborated with Australian Natural Therapeutics Group (ANTG), which produces a variety of cannabis with high levels of cannabidiol (CBD) and low levels...
Well, this is getting a little over the top. Updated directives from the U.S. Navy powers-that-be state sailors and marines are prohibited from more products made or derived from hemp. Section 12619 of the 2018 Farm Bill removed hemp-derived products from Schedule I status under the Controlled Substances Act. However,...
The first (legal) industrial hemp crop to be planted in the U.S. state of Louisiana in modern times is being severely impacted by a fungal disease. What was one the USA's hemp holdout states finally jumped on the nation’s industrial hemp revival bandwagon in June last year when Louisiana Governor...
This first successful export of hemp seed from Australia to New Zealand recently occurred under new legislation removing some roadblocks to Australia's hemp and medicinal cannabis sectors. There wasn't any further detail on the nature of the export - for example if it was hulled seed, raw seed for food...
Tasmanian Institute of Agriculture (TIA) researchers are investigating hemp's potential as a dual-use crop - sheep fodder as well as seed. The research, led by Dr Beth Penrose, will occur over two years and involve trial sites established at TIA’s Forthside research facility situated on Tasmania's north-west coast  and a...
Zelira Therapeutics Ltd (ASX:ZLD) has announced it has signed an agreement with a U.S. company concerning development of cannabinoid based medical products targeting cardiovascular health conditions. The binding product development agreement with Cardiovascular Solutions of Central Mississippi (CVSCM) will see products developed targeting symptoms accompanying Peripheral Arterial Disease (PAD) and...
A cannabis-based formulation developed by Australia's CannPal (ASX:CP1) has substantially reduced atopic dermatitis severity in dogs participating in clinical trial. Atopic dermatitis is triggered by an allergic reaction after a dog ingests or inhales a substance they are sensitive to. As well as being an uncomfortable condition, repeated licking or...